These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14317494)

  • 1. ALUMINUM NICOTINATE: A HYPOCHOLESTEREMIC AGENT.
    MIALE JP
    Curr Ther Res Clin Exp; 1965 Jun; 7():392-400. PubMed ID: 14317494
    [No Abstract]   [Full Text] [Related]  

  • 2. CUTANEOUS EFFECTS OF HYPOCHOLESTEREMIC AGENTS.
    ROE DA
    N Y State J Med; 1964 Oct; 64():2559-63. PubMed ID: 14224225
    [No Abstract]   [Full Text] [Related]  

  • 3. ANTI-ATHEROGENIC EFFECTS OF ALUMINUM NICOTINATE IN THE HYPERCHOLESTEROLEMIC CANINE.
    VASKO J; YOUNGER R; STEPHENSON SE
    Surg Forum; 1963; 14():308-9. PubMed ID: 14065620
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of aluminum nicotinate in hypercholesterolemia.
    PARSONS WB
    Curr Ther Res Clin Exp; 1960 May; 2():137-43. PubMed ID: 14430641
    [No Abstract]   [Full Text] [Related]  

  • 5. [TREATMENT OF HYPERCHOLESTEREMIA WITH COMPLAMIN (7-/2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)-PROPYLTHEOPHYLLINE NICOTINATE)].
    BRANDEL E
    Z Gesamte Inn Med; 1965 May; 20():283-7. PubMed ID: 14306484
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hypercholesterolemia with aluminum nicotinate.
    ZWEIFLER AJ; HOOBLER SW
    J Am Geriatr Soc; 1962 Oct; 10():893-6. PubMed ID: 14004143
    [No Abstract]   [Full Text] [Related]  

  • 7. HYPERCHOLESTEREMIA: EFFECTS OF TREATMENT WITH NICOTINIC ACID FOR THREE TO SEVEN YEARS.
    CHRISTENSEN NA; ACHOR RW; BERGE KG; MASON HL
    Dis Chest; 1964 Oct; 46():411-6. PubMed ID: 14211853
    [No Abstract]   [Full Text] [Related]  

  • 8. A LONG TERM STUDY OF THE EFFECT OF NICOTINIC ACID MEDICATION ON HYPERCHOLESTEREMIA.
    LANGE K; MAHL M
    Am J Med Sci; 1963 Dec; 246():673-7. PubMed ID: 14085222
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of nicotinic acid to reduce serum lipid levels.
    PARSONS WB
    J Am Geriatr Soc; 1962 Oct; 10():850-64. PubMed ID: 13941612
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE USE OF DRUGS IN THE CONTROL OF CHOLESTEROLEMIA].
    ARTEAGALLONA A; DIAZGREZ F; TORRES MC; NUNEZ I
    Sem Med; 1963 Dec; 123():1960-4. PubMed ID: 14128159
    [No Abstract]   [Full Text] [Related]  

  • 11. [BETAIN NICOTINATE IN PROLONGED ORAL FIBRINOLYTIC THERAPY].
    FRANDOLI G; GIBELLI A; TURAZZA G
    Gazz Int Med Chir; 1964 Nov; 68():2065-83. PubMed ID: 14242275
    [No Abstract]   [Full Text] [Related]  

  • 12. ACANTHOSIS NIGRICANS-LIKE LESIONS FROM NICOTINIC ACID.
    TROMOVITCH TA; JACOBS PH; KERN S
    Arch Dermatol; 1964 Feb; 89():222-3. PubMed ID: 14081562
    [No Abstract]   [Full Text] [Related]  

  • 13. MANAGEMENT OF HYPERCHOLESTEROLEMIA.
    BLANKENHORN DH; CHIN HP
    GP; 1964 Apr; 29():135-42. PubMed ID: 14137557
    [No Abstract]   [Full Text] [Related]  

  • 14. [Further research on the hypocholesteremic action of a higher homologue of nicotinic acid: 3-pyridineacetic acid].
    FUMAROLA D; GIORDANO D; DE RINALDIS P
    Minerva Med; 1963 Jan; 54():256-8. PubMed ID: 13960271
    [No Abstract]   [Full Text] [Related]  

  • 15. [ATHEROSCLEROSIS AND CHOLESTEROLEMIA].
    KLEIN L
    Sem Med; 1963 Dec; 123():1871-4. PubMed ID: 14168959
    [No Abstract]   [Full Text] [Related]  

  • 16. THERAPY OF HYPERCHOLESTEROLEMIA.
    GOLDSMITH GA
    Am J Dig Dis; 1964 Sep; 9():651-6. PubMed ID: 14215815
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies on hypocholesteremic agents.
    Paoletti R
    Am J Clin Nutr; 1962 Apr; 10():277-84. PubMed ID: 14038178
    [No Abstract]   [Full Text] [Related]  

  • 18. Nicotinic acid levels as an index of aluminum nicotinate activity in the treatment of hyperlipemia.
    HOLLOMAN JL; DAVIS CC; LEEPER LC
    J Am Geriatr Soc; 1962 Oct; 10():903-5. PubMed ID: 13961366
    [No Abstract]   [Full Text] [Related]  

  • 19. A syndrome of dehydration produced by hypocholesteremic agents.
    KOTTKE BA; BOLLMAN JL; JUERGENS JL
    Proc Staff Meet Mayo Clin; 1962 Jan; 37():1-6. PubMed ID: 14458823
    [No Abstract]   [Full Text] [Related]  

  • 20. A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.
    PEAK HJ; MITCHELL AS; JOSE AD
    Med J Aust; 1965 Jul; 2(5):192-4. PubMed ID: 14348329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.